Urvashi Tyagi - Resmed Chief Officer
| RMEA Stock | EUR 23.60 0.40 1.72% |
Insider
Urvashi Tyagi is Chief Officer of Resmed Inc DRC
| Phone | 858 836 5000 |
| Web | https://www.resmed.com |
Resmed Management Efficiency
The company has return on total asset (ROA) of 0.1155 % which means that it generated a profit of $0.1155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2352 %, meaning that it generated $0.2352 on every $100 dollars invested by stockholders. Resmed's management efficiency ratios could be used to measure how well Resmed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| BBus CPA | Evolution Mining Limited | N/A | |
| Robert BEng | Evolution Mining Limited | N/A | |
| B MAIG | Evolution Mining Limited | 52 | |
| Cheung Fan | Zijin Mining Group | 63 | |
| John Penhall | Evolution Mining Limited | N/A | |
| Hongying Lin | Zijin Mining Group | 55 | |
| MNLP CAHRI | Evolution Mining Limited | N/A | |
| Honghui Wu | Zijin Mining Group | 47 | |
| Laichang Zou | Zijin Mining Group | 55 | |
| ACA ACA | Evolution Mining Limited | 56 | |
| Andrew Millar | Evolution Mining Limited | N/A | |
| Jianhui Wu | Zijin Mining Group | N/A | |
| Fusheng Lan | Zijin Mining Group | 59 | |
| Martin Cummings | Evolution Mining Limited | N/A | |
| Xionghui Xie | Zijin Mining Group | 49 | |
| Jinghe Chen | Zijin Mining Group | 66 | |
| Fiona Murfitt | Evolution Mining Limited | N/A | |
| Kaixi Jiang | Zijin Mining Group | 60 | |
| Hongfu Lin | Zijin Mining Group | 49 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 |
Resmed Inc DRC Leadership Team
Elected by the shareholders, the Resmed's board of directors comprises two types of representatives: Resmed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Resmed. The board's role is to monitor Resmed's management team and ensure that shareholders' interests are well served. Resmed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Resmed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy Wakeham, VP Communications | ||
| Brett Sandercock, Chief Officer | ||
| BE MBA, CEO Director | ||
| Robert Douglas, Pres COO | ||
| Vered Keisar, Chief Officer | ||
| AM AM, Founder Chairman | ||
| David Pendarvis, Global Officer | ||
| Kaushik Ghoshal, Pres Bus | ||
| Constance Bienfait, Director Relations | ||
| Urvashi Tyagi, Chief Officer |
Resmed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Resmed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 31.38 B | |||
| Shares Outstanding | 1.47 B | |||
| Shares Owned By Institutions | 7.92 % | |||
| Price To Earning | 41.55 X | |||
| Price To Book | 9.35 X | |||
| Price To Sales | 8.00 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Resmed Stock
Resmed financial ratios help investors to determine whether Resmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resmed with respect to the benefits of owning Resmed security.